ALVAC-CEA Vaccine

Preferred Label : ALVAC-CEA Vaccine;

NCIt synonyms : ALVAC-CEA;

NCIt definition : A cancer vaccine consisting of ALVAC, a highly attenuated poxvirus strain derived from the canarypox virus, encoding for the tumor associated antigen (TAA) carcinoembryonic antigen (CEA), with potential antineoplastic activity. Upon administration, ALVAC-CEA vaccine expresses CEA and may stimulate a host immune response against tumor cells expressing CEA. This may result in the inhibition of tumor growth and/or metastasis. CEA is overexpressed in a variety of tumor cell types.;

Alternative definition : NCI-GLOSS: A cancer vaccine made with a form of the canarypox virus that does not cause disease in people. It is being studied in the treatment of some kinds of cancer. The virus is changed in the laboratory to make a protein called carcinoembryonic antigen (CEA), which is a tumor marker. ALVAC-CEA vaccine may help the immune system find and kill cancer cells that make CEA.;

Codes from synonyms : CDR0000045455;

Details

Origin ID

C1648;

UMLS CUI

C0338246;

Currated CISMeF NLP mapping
- ALVAC-CEA vaccine [MeSH concept]
- ALVAC-CEA vaccine [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ALVAC-CEA vaccine [MeSH concept]
- ALVAC-CEA vaccine [MeSH Supplementary Concept]
concept_is_in_subset
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
is_component_of_chemotherapy_regimen
- ALVAC-CEA Vaccine/Sargramostim [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients